Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) - a new perspective.

Sumeet Prakash MirghArchana SharmaBhaarat FolbsVishvdeep KhushooJyotsna KapoorNarender TejwaniRayaz AhmedNarendra AgrawalPartha S ChoudharyPallavi MehtaDinesh Bhurani

Published in: Leukemia & lymphoma (2021)

Keyphrases

dendritic cells
regulatory t cells
immune response
multiple myeloma
low grade
chronic lymphocytic leukemia
cell therapy
bone marrow